Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7387 p160
11 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Antiepileptics in pregnancy

Major congenital malformations (MCMs) occur in as little as 4.2 per cent of newborns exposed to antiepileptic drugs in utero (Journal of Neurology, Neurosurgery and Psychiatry 2006;77:193). Antiepileptic polytherapy was associated with a higher rate of MCMs than monotherapy, and regimens containing sodium valproate resulted in significantly more MCMs than those not containing the drug. Exposure to carbamazepine monotherapy was associated with the lowest risk of MCM, the researchers found.

Back to Top


©The Pharmaceutical Journal